Global Biopreservation Market Insights Forecasts to 2033

• The Global Biopreservation Market Size was Valued at USD 2.7 Billion in 2023
• The Market Size is Growing at a CAGR of 22.05% from 2023 to 2033
• The Worldwide Biopreservation Market Size is Expected to Reach USD 19.8 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

 

Get more details on this report -

Request Free Sample PDF

 

The Global Biopreservation Market Size is Anticipated to Exceed USD 19.8 Billion by 2033, Growing at a CAGR of 22.05% from 2023 to 2033.

 

Market Overview

Biopreservation is a technique that helps to preserve the integrity and functionality of biological materials including tissues, stem cells, DNA, and organs under various temperatures, thereby extending their lifespan outside their natural environment. By maintaining biological materials' integrity and usefulness across a variety of temperature conditions, such as tissues, stem cells, DNA, and organs, biopreservation allows prolong the life of these materials away from their natural environments. Stem cell and gene banking are also acquiring worldwide popularity. Biopreservation uses microorganisms and their byproducts of metabolism to improve food safety and extend its shelf life. It allows biospecimens to remain alive longer and safeguards them from harm beyond their natural environment. Biospecimens are material samples such as urine, tissue, blood, DNA, cells, and others that are kept in a bio repository for future studies or use in lab testing. The demand for biospecimen technology has increased due to its wide range of applications in plasma, stem cells, DNA, and tissue research. The surge in adoption has been attributed to specific features that include high-cost effectiveness, storage capacity, and minimal maintenance.

 

Report Coverage

This research report categorizes the market for the global biopreservation market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global biopreservation market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global biopreservation market.

 

Driving Factors

Innovative medical treatments such as organ transplants, stem cell therapy, and regenerative medicine will become more common as healthcare costs rise. These methods require regular preservation of biological samples such as tissues, cells, and organs, resulting in a rising demand for biopreservation solutions that can efficiently sustain the continued existence of these materials while preserving. Furthermore, the establishment of next-generation cryopreservation techniques, improvements to hypothermic preserving formulations, and the combination and design of nanoscale techniques have promoted pharmaceutical companies, biotechnology firms, and hospitals to adopt entirely in-house sample systems, thereby increasing market value. Favorable initiatives from the government, as well as increased use of biopreservation techniques by the world's developing biobanks for the preservation of plasma, cells, tissue, and DNA, will help to drive biopreservation market expansion. To retain their corporate status, organizations in the industry are heavily investing in intensive research and development, as well as strategic mergers, acquisitions, and collaborations.

 

Restraining Factors

Research and development in media solutions that enable biospecimens to be stored at room temperature is expected to hamper the expansion of the global biopreservation market. For instance, the temperature of the room sample stabilization medium solutions including DNA stable and RNA stable are provided by Biomatrica, Inc. These solutions limit the expansion of the freezer and refrigerator market by creating a threat to consumer demand. The lack of qualified workers to handle the biopreservation process, issues with stability with the specimen, and increasing expenses of biopreservation instruments and their upkeep all further hinder market expansion during the evaluation period.

 

Market Segmentation    

The global biopreservation market share is classified into product, application, and end users.

 

• The media segment is expected to hold the largest share of the global biopreservation market during the forecast period.   

Based on the product, the global biopreservation market is divided into media, equipment, and accessories. Among these, the media segment is expected to hold the largest share of the global biopreservation market during the forecast period. This is attributable to the regular and constant purchase of media as compared to equipment, and the media shows their variety and relevance in maintaining biological specimens for different purposes.

 

• The research segment is expected to hold the largest share of the global biopreservation market during the forecast period.

Based on the application, the global biopreservation market is divided into research, and therapeutic. Among these, the research segment is expected to hold the largest share of the global biopreservation market during the forecast period. Increasing research spending in biomedical research, personalized medicine, cell-based research, drug discovery, and various other associated markets is expected to propel the market throughout the estimated time frame.

 

• The bio-banking segment accounted to dominate the global biopreservation market during the forecast period.   

Based on the end users, the global biopreservation market is divided into regenerative medicine, bio- banking, gene bank, hospitals, and drug discovery. Among these, the bio-banking segment accounted to dominate the global biopreservation market during the forecast period. Pharmaceutical companies work with hospitals to preserve tissue while setting aside biobanks. The usage of animal-assisted reproductive technologies, growing acceptance of sperm and egg banking, and growing knowledge of stem cell preservation are all factors contributing to the segment's growth.  The growing need for biospecimens to support several current research fields, including genomics and personalized medicine, will lead to a rise in the use of biobanking and consequent market expansion.

 

Regional Segment Analysis of the Global Biopreservation Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to dominate the global biopreservation market over the predicted timeframe.

 

Get more details on this report -

Request Free Sample PDF

 

North America is anticipated to dominate the global biopreservation market over the predicted timeframe. This can be linked to progress in biomedical research and the development of improved medicines. Furthermore, the growing number of persistent diseases requiring therapy increases demand for biopreservation in the region, boosting its market position. Such actions are projected to help extend the biopreservation product offerings in the market and drive growRemove Anchorth. The biopreservation market in the North America is expected to increase significantly due to the presence of government agencies and different biobanking institutions that encourage the use of biopreservation techniques. For example, the National Institutes of Health (NIH) provides financing for the collecting of biospecimens in biorepositories and biobanks, while the National Cancer Institute (NCI) assists in managing these biobanking initiatives. The nation's clinical trial and research programs are supported by these biobanks, which raises the need for biopreservation methods. Significant government funding for development and research will increase the use of bio-storage, which is expected to drive market growth in the region.

 

Asia Pacific is expected to grow at the fastest pace in the global biopreservation market during the forecast period. Due to its considerable investment in R&D activities, the Asia Pacific has led the industry. To strengthen the market, they employ cutting-edge technologies and talents. Furthermore, growing awareness about the preservation of umbilical cord cells and raised funding in medical research activities would boost economic potential. The accessibility of enough funding from investors, governments, or parent organizations, together with patient awareness, is projected to provide profitable growth possibilities for companies in the global biopreservation market. the region's growing population, rising awareness of stem cell preservation, and ongoing advancements in the healthcare industry primarily due to government support.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global biopreservation market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Avantor, Inc.
• ThermoGenesis Holdings, Inc.
• Bio-Techne Corporation
• BioLife Solutions, Inc.
• Exact Sciences Corporation
• Worthington Industries, Inc.
• Chart Industries, Inc.
• STEMCELL Technologies
• Helmer Scientific Inc.
• So-Low Environmental Equipment Co.
• PrincetonCryo
• AMS Biotechnology (AMSBIO)
• OPS Diagnostics
• Other.

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Developments

• In April 2024, Thermo Fisher Scientific has unveiled its new line of high-performance, ultra-low temperature (ULT) freezers. With improvements to performance, user experience, and energy economy, the Thermo Scientific TSX Universal Series ULT Freezers easily adapt to scientists' workflows in a range of lab environments, ushering in a new era of performance, dependability, and sustainability.

 

• In September 2023, Avantor has signed a deal with Tobin Scientific, a major provider of biopharma cold chain, ambient storage, and transport and logistics services, to assist end-to-end movements for US biopharma customers wishing to relocate their labs, research facilities, and samples. This alliance will address the growing customer need for complicated logistics solutions with temperature-specific requirements.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global biopreservation market based on the below-mentioned segments: 

 

Global Biopreservation Market, By Product

• Media
• Equipment
• Accessories

 

Global Biopreservation Market, By Application

• Research
• Therapeutic

 

Global Biopreservation Market, By End Users

• Regenerative medicine
• Bio- banking
• Gene bank
• Hospitals
• Drug discovery

 

Global Biopreservation Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa